Stephens, 2002, Proc Am Soc Clin Oncol, 21, 1161
Brown, 2003, Proc Am Soc Clin Oncol, 22, 630
Murry, 1997, Pharmacotherapy, 17, 1405
Dumontet, 1999, J Clin Oncol, 17, 1061, 10.1200/JCO.1999.17.3.1061
Williamson, 2003, Proc Am Soc Clin Oncol, 22, 622
Wozniak, 1998, J Clin Oncol, 16, 2459, 10.1200/JCO.1998.16.7.2459
Lilenbaum, 2002, Proc Am Soc Clin Oncol, 21, 2
Delbaldo, 2004, JAMA, 292, 470, 10.1001/jama.292.4.470
Baggstrom, 2003, Proc Am Soc Clin Oncol, 22, 624
Alberola, 2003, J Clin Oncol, 21, 3207, 10.1200/JCO.2003.12.038
Budman, 1998, Anticancer Drugs, 9, 697, 10.1097/00001813-199809000-00005
Le Chevalier, 2005, Lung Cancer, 47, 69, 10.1016/j.lungcan.2004.10.014
Shepherd, 2003, Lung Cancer, 41, S4, 10.1016/S0169-5002(03)91658-8
Raftopoulos, 2003, Proc Am Soc Clin Oncol, 22, 645
Edelman, 2004, Clin Cancer Res, 10, 5022, 10.1158/1078-0432.CCR-04-0002
Zojwalla, 2004, J Clin Oncol, 22, 7068, 10.1200/jco.2004.22.14_suppl.7068
Shepherd, 2004, J Clin Oncol, 22, 7022, 10.1200/jco.2004.22.14_suppl.7022
Gatzemeier, 2004, J Clin Oncol, 22, 7010, 10.1200/jco.2004.22.14_suppl.7010
Herbst, 2004, J Clin Oncol, 22, 7011, 10.1200/jco.2004.22.14_suppl.7011
Miller, 2004, J Clin Oncol, 22, 7061, 10.1200/jco.2004.22.14_suppl.7061
Leighl, 2004, Clin Oncol, 22, 7038, 10.1200/jco.2004.22.14_suppl.7038
Franklin, 2003, Lung Cancer, 41, S147, 10.1016/S0169-5002(03)00158-2
Paez, 2004, Science, 304, 1497, 10.1126/science.1099314
